AXTI.NASDAQAxt INC

10-Q: AXT Inc. Reports Disappointing Q1 2025 Results Amid Trade Tensions and Production Challenges

Sentiment:

Quarterly Report


📋All filings for Axt INC

AXT Inc. reports a net loss for Q1 2025, impacted by trade restrictions, production yield issues, and lower demand for key substrate products.

Delay expectedThe company is facing delays in obtaining export permits for indium phosphide substrates from China.The company's STAR Market IPO for Tongmei is still under review by Chinese authorities.
Worse than expectedThe company reported a net loss compared to a net loss last year.Revenue decreased compared to the same period last year.Gross profit decreased significantly compared to the same period last year.

Summary

  • AXT Inc. reported a net loss attributable to AXT, Inc. of $8.8 million, or $0.20 per share, for the first quarter of 2025, compared to a net loss of $2.1 million, or $0.05 per share, for the first quarter of 2024.
  • Revenue decreased by 14.7% to $19.4 million from $22.7 million in the same period last year.
  • The decrease in revenue was primarily due to lower demand for GaAs and InP wafer substrates.
  • Gross profit decreased significantly to a loss of $1.2 million, compared to a gross profit of $6.1 million in Q1 2024, primarily due to unfavorable yields in gallium arsenide production.
  • The company is facing challenges related to trade restrictions between the U.S. and China, which are impacting its ability to export products.
  • AXT is actively seeking export permits for indium phosphide substrates but the timing of approval remains uncertain.
  • The company's STAR Market IPO for Tongmei is still under review by Chinese authorities.
  • The company has $38.2 million in cash and restricted cash as of March 31, 2025.
  • The company believes it has adequate cash and investments to meet its operating needs and capital expenditures over the next 12 months.

Sentiment

Score: 3

Explanation: The document presents a negative outlook due to decreased revenue, a net loss, and challenges related to trade restrictions and production issues. The uncertainty surrounding the Tongmei IPO and export permits further contributes to the negative sentiment.

Positives

  • Raw materials sales increased $2.5 million, or 43.0%, to $8.3 million for the three months ended March 31, 2025 as compared to the same period in 2024.
  • The company believes it has adequate cash and investments to meet its operating needs and capital expenditures over the next 12 months.
  • Revenue in China increased $1.9 million for the three months ended March 31, 2025, primarily due to higher demand for our GaAs wafer substrates and refined gallium sold by one of our consolidated subsidiaries.

Negatives

  • The company reported a net loss attributable to AXT, Inc. of $8.8 million, or $0.20 per share, for Q1 2025.
  • Revenue decreased by 14.7% to $19.4 million compared to Q1 2024.
  • Gross profit decreased significantly to a loss of $1.2 million, compared to a gross profit of $6.1 million in Q1 2024.
  • The company is facing challenges related to trade restrictions between the U.S. and China, impacting exports and increasing costs.
  • The company is actively seeking export permits for indium phosphide substrates but the timing of approval remains uncertain.
  • The company's STAR Market IPO for Tongmei is still under review by Chinese authorities.

Risks

  • Escalating trade tensions and regulations between the U.S. and China are impacting the company's ability to export products and increasing costs.
  • The company is facing challenges related to obtaining export permits from China for its substrate products.
  • The company's STAR Market IPO for Tongmei is still under review by Chinese authorities and may not be completed.
  • The company is facing challenges related to unfavorable yields in gallium arsenide production.
  • The company is facing challenges related to lower demand for InP wafer substrates used for data center applications and in passive optical networks and weaker demand for Ge wafer substrates in China.
  • The company is facing challenges related to the potential for the Chinese government to intervene in or influence its PRC operations.
  • The company is facing challenges related to the potential for the Chinese government to change the rules and regulations in China.
  • The company is facing challenges related to the potential for the Chinese government to exert more control over offerings conducted overseas and/or foreign investment in China-based issuers.
  • The company is facing challenges related to the potential for changes in Chinas political, social, regulatory or economic environments.
  • The company is facing challenges related to the potential for joint venture raw material companies in China to bring certain risks.
  • The company is facing challenges related to the potential for the Chinese central government to be increasingly aware of air pollution and other forms of environmental pollution and their reform efforts can impact our manufacturing, including intermittent mandatory shutdowns.
  • The company is facing challenges related to the potential for shutdowns or underutilizing our manufacturing facilities may result in declines in our gross margins.
  • The company is facing challenges related to the potential for escalating and volatile trade tariffs, import restrictions, export restrictions, Chinese regulations or other trade barriers may materially harm our business.
  • The company is facing challenges related to the potential for China to place restrictions on freight and transportation routes and on ports of entry and departure this could result in shipping delays or increased costs for shipping.
  • The company is facing challenges related to the potential for our international operations to be exposed to potential adverse tax consequence in China.
  • The company is facing challenges related to the potential for our gross margin to fluctuate historically and may decline or increase due to several factors.
  • The company is facing challenges related to the potential for the terms of the private equity raised by Tongmei in China grant each investor a right of redemption if the IPO fails to pass the audit of the Shanghai Stock Exchange, is not approved by the CSRC or Tongmei cancels the IPO application.
  • The company is facing challenges related to the potential for us to be subject to foreign exchange gains and losses that materially impact our condensed consolidated statements of operations.

Future Outlook

The company believes it has adequate cash and investments to meet its operating needs and capital expenditures over the next 12 months, but faces uncertainty due to trade tensions and other factors.

Industry Context

The semiconductor industry is cyclical and faces challenges related to trade tensions, supply chain disruptions, and changing demand patterns.

Comparison to Industry Standards

  • The document does not contain enough information to compare the results to industry standards.
  • To compare to industry standards, specific details about comparable companies, projects, and results would be needed.

Legal Proceedings

  • A putative shareholder class action complaint was filed in the U.S. District Court for the Eastern District of New York on May 6, 2024, alleging violations of federal securities laws.
  • A derivative lawsuit was filed in the Northern District of California on August 22, 2024, alleging breach of fiduciary duties.

Stakeholder Impact

  • Shareholders are negatively impacted by the net loss and the decline in stock price.
  • Employees may be impacted by potential cost-cutting measures or restructuring plans.
  • Customers may be impacted by potential delays in product shipments due to trade restrictions or production issues.
  • Suppliers may be impacted by potential changes in sourcing strategies or reduced orders.

Next Steps

  • The company is actively seeking export permits for indium phosphide substrates from China.
  • The company is awaiting review and approval of the Tongmei IPO by Chinese authorities.
  • The company is working to improve yields in gallium arsenide production.

Key Dates

DateDescription
March 24, 2021Start of the putative class period for the shareholder class action complaint.
April 3, 2024End of the putative class period for the shareholder class action complaint.
May 6, 2024A putative shareholder class action complaint was filed in the U.S. District Court for the Eastern District of New York.
August 22, 2024A derivative lawsuit was filed in the Northern District of California.
March 31, 2025End of the period covered by this Quarterly Report on Form 10-Q.
April 14, 2025The Court entered judgment on April 14, 2025.
May 13, 2025Plaintiffs filed a notice of appeal.
May 14, 2025Date of the report.

Keywords

AXT Inc., Financial Results, Q1 2025, Trade Restrictions, Substrates, Gallium Arsenide, Indium Phosphide, STAR Market IPO, Tongmei, China, Export Permits, Net Loss, Revenue, Gross Profit, Manufacturing, Semiconductors

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.